Cargando…
Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives
Despite relentless efforts to improve outcome, the prognosis of glioblastoma (GBM) remains poor. Standard therapy at first diagnosis consists of maximal safe surgical resection followed by radiochemotherapy, but treatment options at recurrence are scarce and have limited efficacy. Immunotherapy is a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237336/ https://www.ncbi.nlm.nih.gov/pubmed/37275902 http://dx.doi.org/10.3389/fimmu.2023.1183641 |